U.S. Physical Therapy's fundamental outlook is characterized by erratic revenue swings and severe margin compression, with gross margins collapsing to 14.5% in Q1 2026 from a historical 17-25% range, suggesting significant cost structure vulnerability.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 4, 2026 | $0.80+5.8% vs $0.76 | $223M+3.8% vs $214M |
Q3 2026 Aug 5, 2026 | $0.75-7.9% vs $0.81 | $214M+1.3% vs $211M |
Q2 2026 May 6, 2026 | $0.46-16.4% vs $0.55 | $198M-1.3% vs $201M |
Q1 2026 Feb 25, 2026 | $0.67+0.0% vs $0.67 | $203M+1.4% vs $200M |
U.S. Physical Therapy, Inc. (NYSE: USPH - Get Free Report)'s stock price reached a new 52-week high during trading on Thursday following a better than expected earnings announcement. The company traded as high as $100.98 and last traded at $99.4060, with a volume of 19,499 shares trading hands. The stock had previously closed at $89.18. The
U.S. Physical Therapy, Inc. ( USPH ) Q3 2026 Earnings Call November 5, 2026 10:30 AM EST Company Participants Christopher Reading - CEO & Chairman Jason Curtis - Senior Vice President of Finance Nchacha Etta - Executive VP & CFO Eric Williams - President & COO Conference Call Participants Joanna Gajuk - BofA Securities, Research Division Jack Slevin - Jefferies LLC, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Lawrence Solow - CJS Securities, Inc. Constantine Davides - Citizens JMP Securities, LLC, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the U.S. Physical Therapy Third Quarter 2026 Earnings Call.
While the top- and bottom-line numbers for U.S. Physical Therapy (USPH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.66 per share a year ago.
Benchmark USPH against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for U.S. Physical Therapy, Inc. (USPH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $99.49 | $1.51B | -666.38 | 16.33% | -0.27% | -0.29% | 1.81% | |
| $3.17 | $72.3M | 3.37 | -39.65% | 60.78% | 11.48% | 27.39% | |
| $208.85 | $3.26B | 29.08 | 16.94% | 7.24% | 10.35% | 1.18% | |
| $181.08 | $10.55B | 26.91 | 18.72% | 7.03% | 16.61% | 0.14% | |
| $37.00 | $3.44B | -3.01 | 5.04% | -33.07% | -51.55% | — | |
| $23.20 | $3.03B | -33.73 | 6.24% | -2.63% | -2.59% | — |
U.S. Physical Therapy, Inc. (USPH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
U.S. Physical Therapy, Inc. (USPH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jul 6, 2026·SEC
May 19, 2026·SEC
Get notified when USPH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
U.S. Physical Therapy, Inc. (USPH) stock FAQ — growth, dividends, profitability & financials explained
U.S. Physical Therapy, Inc. (USPH) reported $837.6M in revenue over the trailing twelve months. Revenue was $781.0M in fiscal year 2025. That is 2325% more than the $32.2M of fiscal year 1996.
U.S. Physical Therapy, Inc. (USPH) grew revenue by 26.7% over the trailing twelve months, compared with the twelve months before.
No. U.S. Physical Therapy, Inc. (USPH) reported a net loss of $2.2M over the trailing twelve months.
Yes. U.S. Physical Therapy, Inc. (USPH) pays a dividend that yields 1.81% at the current price, a moderate yield.
U.S. Physical Therapy, Inc. (USPH) had a return on equity (ROE) of -0.3% over the trailing twelve months. A negative ROE means the company lost money over the period.
U.S. Physical Therapy, Inc. (USPH) generated $69.1M in free cash flow over the trailing twelve months.
